Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cellsCOPPO, Paul; DUSANTER-FOURT, Isabelle; SAINTENY, Francoise et al.Oncogene (Basingstoke). 2003, Vol 22, Num 26, pp 4102-4110, issn 0950-9232, 9 p.Article

Lipocalin 2 is required for BCR-ABL-induced tumorigenesisLENG, X; LIN, H; ADEREM, A et al.Oncogene (Basingstoke). 2008, Vol 27, Num 47, pp 6110-6119, issn 0950-9232, 10 p.Article

BCR―ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patientsDE CARVALHO, D. D; BINATO, R; CASTRO, F. A et al.Oncogene (Basingstoke). 2011, Vol 30, Num 2, pp 223-233, issn 0950-9232, 11 p.Article

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effectsPERAZZONA, B; LIN, H; SUN, T et al.Oncogene (Basingstoke). 2008, Vol 27, Num 15, pp 2208-2214, issn 0950-9232, 7 p.Article

Bcr-Abl induces autocrine IGF-1 signalingLAKSHMIKUTTYAMMA, A; PASTURAL, E; TAKAHASHI, N et al.Oncogene (Basingstoke). 2008, Vol 27, Num 27, pp 3831-3844, issn 0950-9232, 14 p.Article

Inhibition of phosphorylation of p160 BCR within p210 BCR-ABL complexes during early stages of phorbol ester-induced differentiation of K562 cellsCAMPBELL, P. L; DAI LU; JIE QIANG GUO et al.Cell growth and differentiation. 1993, Vol 4, Num 7, pp 581-588, issn 1044-9523Article

BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage responseGRIAUD, François; WILLIAMSON, Andrew J. K; TAYLOR, Samuel et al.Journal of proteomics (Print). 2012, Vol 77, pp 14-26, issn 1874-3919, 13 p.Article

A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translationNOTARI, Mario; NEVIANI, Paolo; PERROTTI, Danilo et al.Blood. 2006, Vol 107, Num 6, pp 2507-2516, issn 0006-4971, 10 p.Article

JunB is a gatekeeper for B-lymphoid leukemiaOTT, R. G; SIMMA, O; SEXL, V et al.Oncogene (Basingstoke). 2007, Vol 26, Num 33, pp 4863-4871, issn 0950-9232, 9 p.Article

Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cellsESSAFI, Abdelkader; FERNANDEZ DE MATTOS, Silvia; HASSEN, Yasmin A. M et al.Oncogene (Basingstoke). 2005, Vol 24, Num 14, pp 2317-2329, issn 0950-9232, 13 p.Article

Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr/AblCHEN, Ying-Jung; CHANG, Long-Sen.Molecular nutrition & food research (Print). 2012, Vol 56, Num 9, pp 1398-1412, issn 1613-4125, 15 p.Article

The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblastsDALEY, G. Q; MCLAUGHLIN, J; WITTE, O. N et al.Science (Washington, D.C.). 1987, Vol 237, Num 4814, pp 532-535, issn 0036-8075Article

Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemiaARLINGHAUS, Ralph B.Oncogene (Basingstoke). 2002, Vol 21, Num 56, pp 8560-8567, issn 0950-9232, 8 p.Article

Mutation-specific control of BCR-ABL T315I positive leukemia with a recombinant yeast-based therapeutic vaccine in a murine modelBUI, Melanie R; HODSON, Victoria; DEGREGORI, James et al.Vaccine. 2010, Vol 28, Num 37, pp 6028-6035, issn 0264-410X, 8 p.Article

Detection of ABL kinase domain mutations with denaturing high-performance liquid chromatographyDEININGER, M. W. N; MCGREEVEY, L; WILLIS, S et al.Leukemia. 2004, Vol 18, Num 4, pp 864-871, issn 0887-6924, 8 p.Article

Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteinsPERROTTI, Danilo; CALABRETTA, Bruno.Oncogene (Basingstoke). 2002, Vol 21, Num 56, pp 8577-8583, issn 0950-9232, 7 p.Article

Bcr-abl-mediated suppression of normal hematopoiesis in leukemiaHUI LIN; MONACO, Giuseppe; TONG SUN et al.Oncogene (Basingstoke). 2005, Vol 24, Num 20, pp 3246-3256, issn 0950-9232, 11 p.Article

Assessment of downstream effectors of BCR/ABL protein tyrosine kinase using combined proteomic approachesCHIA FANG LEE; GRIFFITHS, Stephen; RODRIGUEZ-SUAREZ, Eva et al.Proteomics (Weinheim. Print). 2010, Vol 10, Num 18, pp 3321-3342, issn 1615-9853, 22 p.Article

Chronic myelogenous leukemia molecular signatureNOWICKI, Michal Oskar; PAWLOWSKI, Peter; FISCHER, Thomas et al.Oncogene (Basingstoke). 2003, Vol 22, Num 25, pp 3952-3963, issn 0950-9232, 12 p.Article

Graphene sheets, polyaniline and AuNPs based DNA sensor for electrochemical determination of BCR/ABL fusion gene with functional hairpin probeLI WANG; ERHUI HUA; MO LIANG et al.Biosensors & bioelectronics. 2014, Vol 51, pp 201-207, issn 0956-5663, 7 p.Article

C/EBPδ expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiationGERY, Sigal; TANOSAKI, Sakae; HOFMANN, Wolf-K et al.Oncogene (Basingstoke). 2005, Vol 24, Num 9, pp 1589-1597, issn 0950-9232, 9 p.Article

Kinase drug discovery approaches in chronic myeloproliferative disordersKUMAR, C; PURANDARE, A. V; LEE, F. Y et al.Oncogene (Basingstoke). 2009, Vol 28, Num 24, pp 2305-2313, issn 0950-9232, 9 p.Article

p210^BCR/ABL-induced alteration of pre-mRNA splicing in primary human CD34⁺ hematopoietic progenitor cellsSALESSE, S; DYLLA, S. J; VERFAILLIE, C. M et al.Leukemia. 2004, Vol 18, Num 4, pp 727-733, issn 0887-6924, 7 p.Article

Philadelphia-positive leukemia: a personal perspectiveHEISTERKAMP, Nora; GROFFEN, John.Oncogene (Basingstoke). 2002, Vol 21, Num 56, pp 8536-8540, issn 0950-9232, 5 p., NS7Article

Overproduction of BCR-ABL induces apoptosis in imatinib mesylate-resistant cell linesDESPLAT, Vanessa; BELLOC, Francis; LAGARDE, Valkrie et al.Cancer. 2005, Vol 103, Num 1, pp 102-110, issn 0008-543X, 9 p.Article